Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)


The Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required) funding program from the National Institutes of Health (NIH) supports research on expectancy-generating factors and measures of their effects on expectancies and subsequent cancer symptom management outcomes; and research to identify moderators of such expectancy effects. Specifically, this program supports mechanistic research that aims to understand how and why expectancy effects occur in a cancer context, elucidate their role in cancer symptom management, and identify patients, symptoms, cancer sites, and contexts in which expectancy effects can be leveraged to improve cancer outcomes. Expectancies are defined in this context as beliefs about future outcomes, including ones response to cancer or cancer treatment. Expectancies can be evoked by social, psychological, environmental, and systemic factors. Expectancy effects are the cognitive, behavioral, and biological outcomes caused by expectancies. Expectancy effects can be generated by expectancies held by patients, clinicians, family members, caregivers, and/or dyadic/social networks. The program is particularly interested in applications that enroll individuals and groups from populations historically underrepresented or excluded from biomedical and behavioral research. Applications are open to researchers in the USA and worldwide. Applicants may apply for 5 years of research funding. Opportunity ID: PAR-23-155. Full applications are due June 15, 2023.

Be the first to know

Sign-up for Personalized Grant alerts

Sign-up for the
monthly research
funding newsletter

You can unsubscribe at any time.